Previous studies have suggested that
minocycline can attenuate cognitive deficits in animal models of conditions such as
Alzheimer's disease and
cerebral ischemia through inhibiting microglia associated anti-inflammatory actions. However the pathway that
minocycline targets to enhance cognitive performance is not fully defined. Here we examined the effects of
minocycline on learning and memory in aged (22-month-old) C57 BL/6 mice. We treated one group of mice with
minocycline (30 mg/kg/day), and another group of mice with
donepezil (2 mg/kg/day) as a positive control. The Morris water maze and passive avoidance tests were used to evaluate the effects of
minocycline on learning and
memory deficits. We also used high-frequency stimulation-induced long-term potentiation and Golgi-Cox staining to assess the effect of
minocycline on synaptic plasticity and synaptogenesis. The effects of
minocycline on synapse-associated signaling
proteins were determined by western blot. We found that
minocycline ameliorates cognitive deficits, enhances neuroplasticity, activates
brain-derived neurotrophic factor-
extracellular signal-regulated kinases signaling and increases expression of
Arc, EGR1 and PSD-95 in the CA1 and dentate gyrus regions of the hippocampus in aged mice. The effects of
minocycline in aged mice were similar to those of
donepezil. Our results suggest that
minocycline could improve learning and memory through enhancing synaptic plasticity and synaptogenesis, modulating the expression of synapse-associated signaling
proteins, which provide a rationale for exploring the viability of using
minocycline treatment in cognitive deficits.